Publications by authors named "Iavarone Massimo"

Claim this Profile
A
ASAP score predicts early HCC recurrence after complete radiological response to locoregional treatments.
Lorenzo Canova, Massimo Iavarone, Eleonora Alimenti, Mariangela Bruccoleri, Lorenzo Argiento

Dig Liver Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Concept of "Converse Therapeutic Hierarchy" for Patients with Hepatocellular Carcinoma.
Alessandro Vitale, Giuseppe Cabibbo, Lorenza Rimassa, Massimo Iavarone, Agostino Colli

Liver Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study.
Massimo Iavarone, Eleonora Alimenti, Massimo Puoti, Hamid Hasson, Bianca Monti

Liver Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab.
Andrea Dalbeni, Filippo Cattazzo, Marco Vicardi, Eugenio Franceschini, Claudia Campani, Massimo Iavarone

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab.
Leonardo Stella, Giuseppe Cabibbo, Ciro Celsa, Roberta Ciccia, Alba Sparacino, Massimo Iavarone

Liver Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy.
Marta Fortuny, Leonardo G da Fonseca, Manon Allaire, Rocío Sánchez, Jean-Charles Nault, Massimo Iavarone

Liver Int· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic Therapy.
Camilla De Carlo, Reha Akpinar, Barbara Durante, Tiziana Pressiani, Julien Calderaro, Massimo Iavarone, Massimo Roncalli

Liver Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of BCLC recommendations on survival for patients with hepatocellular carcinoma.
Massimo Iavarone, Eleonora Alimenti, Lorenzo Canova, Mariangela Bruccoleri, Barbara Antonelli

Hepatol Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study.
Alessandro Vitale, Jung Sun Kim, Giuseppe Cabibbo, Andrea Casadei-Gardini, Massimo Iavarone

Liver Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study.
Mara Persano, Andrea Casadei-Gardini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Massimo Alberto Iavarone

Oncology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab.
Bernardo Stefanini, Fabio Piscaglia, Fabio Marra, Massimo Iavarone, Caterina Vivaldi

Liver Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of patients with advanced HCC receiving atezolizumab/bevacizumab: Take care of cirrhosis!
Jean-Charles Nault, Massimo Iavarone

Hepatology· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of Death.
Giuseppe Cabibbo, Ciro Celsa, Salvatore Battaglia, Marco Enea, Gabriele Di Maria, Massimo Iavarone

Clin Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to "Pioneering applications of immunotherapy in the early stages of hepatocellular carcinoma" [Digestive and Liver Disease 56 (2024) 2011-2021].
Eleonora Alimenti, Erica Nicola Lynch, Leonardo Antonio Natola, Massimo Iavarone

Dig Liver Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
We need evidence-based futility thresholds to transplant grade-3 acute on chronic liver failure patients with poor respiratory, haemodynamic, and metabolic parameters.
Alfonso W Avolio, Massimo Antonelli, Lucio Caccamo, Francesco Frongillo, Luca Del Prete, Massimo Iavarone

Lancet Reg Health Eur· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma.
Parissa Tabrizian, Rebecca Marino, Sherrie Bhoori, Marcus Zeitlhoefler, Neil Mehta, Massimo Iavarone

JHEP Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pioneering applications of immunotherapy in the early stages of hepatocellular carcinoma.
Alimenti Eleonora, Erica Nicola Lynch, Leonardo Antonio Natola, Iavarone Massimo

Dig Liver Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis.
Simone Di Cola, Gennaro D'Amico, Paolo Caraceni, Filippo Schepis, Simone Loredana, Massimo Iavarone

J Hepatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palliative care in patients with hepatocellular carcinoma: Results from a survey among hepatologists and palliative care physicians.
Massimo Iavarone, Lorenzo Canova, Eleonora Alimenti, Alessio Aghemo, Diego Taveggia

Palliat Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study.
Federico Rossari, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Massimo Iavarone

Liver Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab.
Margherita Rimini, Margarida Montes, Elisabeth Amadeo, Francesco Vitiello, Masatoshi Kudo, Massimo Iavarone

Sci Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection.
Atish Mukherji, Frank Jühling, Yogy Simanjuntak, Emilie Crouchet, Fabio Del Zompo, Massimo Iavarone, Massimo Colombo

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab.
Mara Persano, Margherita Rimini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Massimo Alberto Iavarone

Target Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in Lenvatinib.
Massimo Iavarone, Eleonora Alimenti, Toshifumi Tada, Shigeo Shimose, Goki Suda

Liver Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib.
Maurizio Biselli, Nicola Reggidori, Massimo Iavarone, Matteo Renzulli, Lorenzo Lani, Massimo Marignani

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis